Lee Joseph G H, Telford Jennifer J, Galorport Cherry, Yonge Jordan, Macdonnell Christopher A, Enns Robert A
Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Department of Medicine, Division of Gastroenterology, St Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada.
J Can Assoc Gastroenterol. 2020 Sep 16;4(5):207-213. doi: 10.1093/jcag/gwaa031. eCollection 2021 Oct.
The British Columbia Colon Screening Program (BCCSP) is a population-based colon cancer screening program. In December 2018, physicians in Vancouver, Canada agreed to switch from a low-volume split preparation to a high-volume polyethylene glycol preparation after a meta-analysis of studies suggested superiority of the higher volume preparation in achieving adequate bowel cleansing and improving adenoma detection rates.
To compare the quality of bowel preparation and neoplasia detection rates using a high-volume split preparation (HVSP) versus a low-volume split preparation (LVSP) in patients undergoing colonoscopy in the BCCSP.
A retrospective review of patients undergoing colonoscopy through the BCCSP at St. Paul's Hospital from July 2017 to November 2018 and December 2018 to November 2019 was conducted. Inclusion criteria included age 50 to 74 and patients undergoing colonoscopy through the BCCSP. Variables collected included patient demographics and bowel preparation quality. Rates of bowel preparation and neoplasia detection were analyzed using chi-squared test.
A total of 1453 colonoscopies were included, 877 in the LVSP group and 576 in the HVSP group. No statistically significant difference was noted between rates of inadequate bowel preparation (LVSP 3.6% versus HVSP 2.8%; = 0.364). Greater rates of excellent (48.4% versus 40.1%; = 0.002) and optimal (90.1% versus 86.5%; = 0.041) bowel preparation were achieved with HVSP. The overall adenoma detection rate was similar between the two groups (LVSP 53.1% versus HVSP 54.0%; = 0.074). LVSP demonstrated higher overall sessile serrated lesion detection rate (9.5% versus 5.6%; = 0.007).
Compared to LVSP, HVSP was associated with an increase in excellent and optimal bowel preparations, but without an improvement in overall neoplasia detection.
不列颠哥伦比亚省结肠癌筛查项目(BCCSP)是一项基于人群的结肠癌筛查项目。2018年12月,在对多项研究进行荟萃分析表明高容量制剂在实现充分肠道清洁和提高腺瘤检出率方面具有优势后,加拿大温哥华的医生同意从低容量分次制剂改用高容量聚乙二醇制剂。
在BCCSP中,比较接受结肠镜检查的患者使用高容量分次制剂(HVSP)与低容量分次制剂(LVSP)时的肠道准备质量和肿瘤检出率。
对2017年7月至2018年11月以及2018年12月至2019年11月期间在圣保罗医院通过BCCSP接受结肠镜检查的患者进行回顾性研究。纳入标准包括年龄在50至74岁之间以及通过BCCSP接受结肠镜检查的患者。收集的变量包括患者人口统计学资料和肠道准备质量。使用卡方检验分析肠道准备率和肿瘤检出率。
共纳入1453例结肠镜检查,LVSP组877例,HVSP组576例。肠道准备不充分的发生率之间无统计学显著差异(LVSP为3.6%,HVSP为2.8%;P = 0.364)。HVSP实现了更高的优质(48.4%对40.1%;P = 0.002)和最佳(90.1%对86.5%;P = 0.041)肠道准备率。两组的总体腺瘤检出率相似(LVSP为53.1%,HVSP为54.0%;P = 0.074)。LVSP显示出更高的总体无蒂锯齿状病变检出率(9.5%对5.6%;P = 0.007)。
与LVSP相比,HVSP与优质和最佳肠道准备的增加相关,但总体肿瘤检出率没有改善。